HRD Tests for Ovarian cancER

Inclusion Criteria

• •Patient aged 18-year or more
• •Histologically documented high grade serous epithelial ovarian cancer, fallopian tube or peritoneum cancer
• •Newly diagnosed advanced (International Federation of Gynecology and Obstetrics \[FIGO\] stage III or IV) ovarian carcinoma, candidate to a first line platinum-based chemotherapy
• •Tumor tissue must be available for HRD analyses (FFPE tissue block) and
• •* Collected if possible during the initial surgery or the initial biopsy (before chemotherapy)
• •* With sufficient tumour surface area (\> 25 mm²), with a final cellularity of at least 20%
• •Patient affiliated to an appropriate social security system
• •Patient signed consent form before any trial related activities